Parkwood LLC’s Edwards Lifesciences EW Stock Holding History

Parkwood LLC’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-11,043	Closed	-$345K	–	512
2016 Q4	$345K	Buy	11,043 +4,071	+58%	+$132K	0.05%	257
2016 Q3	$280K	Sell	6,972 -5,640	-45%	-$212K	0.04%	367
2016 Q2	$419K	Hold	12,612	–	–	0.07%	296
2016 Q1	$371K	Sell	12,612 -14,004	-53%	-$386K	0.06%	349
2015 Q4	$701K	Hold	26,616	–	–	0.11%	114
2015 Q3	$631K	Sell	26,616 -8,784	-25%	-$212K	0.1%	112
2015 Q2	$840K	Hold	35,400	–	–	0.12%	87
2015 Q1	$841K	Hold	35,400	–	–	0.11%	86
2014 Q4	$752K	Buy	35,400 +13,362	+61%	+$268K	0.1%	80
2014 Q3	$375K	Buy	+22,038	New	+$348K	0.08%	192
2014 Q1	–	Sell	-17,574	Closed	-$193K	–	252
2013 Q4	$193K	Buy	+17,574	New	+$198K	0.05%	165

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Parkwood LLC's EW Position: Q1 2017 in Review

Parkwood LLC sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 11,043 shares — an estimated $345K sold.

Parkwood LLC first reported a position in EW in Q4 2013 and held it in 11 quarters. The position peaked at $841K in Q1 2015. 691 funds tracked by Wall St. Rank hold EW as of Q1 2017.

Parkwood LLC reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
Parkwood LLC sold 11,043 Edwards Lifesciences shares in Q1 2017, an estimated $345K.
Parkwood LLC first reported a position in Edwards Lifesciences in Q4 2013 and held it in 11 quarters.
Parkwood LLC's Edwards Lifesciences position peaked at $841K in Q1 2015.
691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on Parkwood LLC's 13F filing for Q1 2017, filed 5 May 2017.